GL1X · GenesisL1 explorer

Research workbench

Structure of the P pilus usher (papc) translocation pore

Analyse Structure of the P pilus usher (papc) translocation pore in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2VQI
Type
protein
Length
954 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Outer membrane usher protein papc
UniProt
P07110
Pockets
9 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 3% helix, 67% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AOuter membrane usher protein papcprotein4773% helix, 67% strandP07110
BOuter membrane usher protein papcprotein4773% helix, 67% strandP07110

Ligands and binding sites

  • LDA · Lauryl dimethylamine-N-oxide · additive · 2 copies · chains A, B
  • C8E · (hydroxyethyloxy)tri(ethyloxy)octane · additive · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111720.790.81121empty
28810.790.82106empty
310000.780.80125empty
48940.710.76108empty
53250.640.8134empty

Interfaces

1 interface between chains.

  • A–B · 1248 Ų buried · 24 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 16 modified (engineered).

Compared structures

  • 2VQI · Structure of the P pilus usher (PapC) translocation pore · the same entry in another collection · chain B against B, TM-score 1.00
  • P07110 · AlphaFold monomer V2.0 prediction for outer membrane usher protein papc (P07110) · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.